endothelial system by which they are produced. Their presence in the marrow appears to be evidence of fundamental change which is not to be expected from simple marrow exhaustion but may be due to circulating iso-and auto-antibodies.
FANCONI, G. (1927) Jb. Kinderheilk., 117, 257. GASSER, C. (1949) Helv. pawdiat. acta, 4, 107. (1955) Sang, 26, 6. RICHET, G., ALAGILLE, D., and FOURNIER, E. (1954) Pr. mid., 62, 50. SMITH, C. H. (1949) Blood, 4, 697. (1953) London THROMBOCYTHEMIA is relatively rare: it may be associated with other myeloproliferative disorders such as polycythemia vera and myeloid leukemia, and a secondary increase in platelets has been recorded following trauma, acute blood loss, splenectomy, and splenic atrophy. Primary thrombocythlumia has been described.by Epstein and Kretz (1930) , Rowlands and Vaizey (1938) , Reid (1940) , Owren (1943), Fanger and co-workers (1954) and Pudldk and others (1955) . An attempt has been made to differentiate between heemorrhagic and nonheemorrhagic forms of this condition by Hardisty and Wolff (1955) . They found in the literature 18 previously recorded cases of primary thrombocythimia with haemorrhagic manifestations, and added 5 further cases.
We present here 3.cases of primary thrombocythemia in each of whom hemorrhage was observed; .in 1 case thromboses were also recorded. Hardisty and Wolff (1955) demonstrated by the thromboplastin-generation test poor thromboplastin formation in their 5 patients; we have found a similar abnormality in the platelets of our cases. By comparison the platelets of 3 further patients with thrombocythaemia behaved normally in the thromboplastin-generation test; these were considered to be cases of secondary thrombocythaemia.
BRIEF CASE NomS
In these 3 patients with primary thrombocythlmia there was no relevant family history. Case I.-Mrs. D. W., aged 55, had had Parkinson's disease diagnosed six years previously. When seen in January 1956 she gave a four-year history of repeated severe epistaxes.
Over the last two years the platelet count has varied between 1,150,000 and 3,830,000/c.mm.: the bleeding time, by Duke's method, was prolonged on one occasion to eight minutes. There has also been a mild hypochromic anvmia and the white cell count has never risen above 13,000/c.mm., an occasional myelocyte being seen. Epistaxes have recurred recently.
Case II.-Mr. R. G., aged .32, had been invalided from the Navy with a right hemiplegia with only partial recovery, considered due to cerebral thrombosis. In 1950 he had a bilateral sympathectomy for poor circulation in the feet. From early 1955 he had had occasional epileptic fits. When first seen in the summer of 1955 he had hematuria and ecchymoses in both thighs and in the left iliac region, during treatment with small doses of Dindevan given with careful laboratory control; the prothrombin time never rose to more than twice the control time.
The ECG showed evidence of previous anterior coronary infarction. His platelet count over the past two and a half years has varied between 700,000 and 1 ,800,000/c.mm. The hemoglobin, red cell count, and volume of packed cells are normal and the leucocyte count has never risen above 14,000/c.mm.
Case llI.-Mrs. E. A., aged 43, gave no relevant past history. She was admitted in November 1955. Two weeks before, she bled for seventy-two hours following a dental extraction, which had necessitated repeated blood transfusions. Over the past two years the platelet count has varied between 1,360,000 and 1,560,000/c.mm. The bleeding time was markedly prolonged on two occasions. The leucocyte count has remained normal. There have been no reports of further hemorrhages.
In the above 3 patients there was no enlargement of lymph nodes or liver and the spleen was palpable in Case III only.
The brief case notes of the 3 patients considered as cases of secondary thrombocythemia (post-hEemorrhagic type) are as follows; in none was there any relevant family history.
Case IV.-Mr. A. L., aged 55, was admitted in April 1957 with melkna following a hematemesis.
There was no relevant past history. Investigation showed a hemoglobin level of 3-9 g./l00 ml., a white count of 1,000/c.mm. and platelets between 810,000 and 880,000/c.mm. Barium meal and gastroscopy were negative. His treatment included blood transfusion and iron. He has had no further hmemorrhage and a recent blood count shows a normal platelet level. Case V.-Mrs. S. T., aged 84, was admitted in April 1957, in cardiac failure secondary to cardiac ischmmia. She had extensive ecchymoses from the left thigh to the ankle and petechime on the palate. Three years before she had had similar extensive ecchymoses of the left arm and chest. The platelet count was between 1,400,000 and 1,500,000/c.mm. on three occasions, the white cell count was 9,300/c.mm. An ascorbic acid excretion test confirmed a diagnosis of scurvy. She was discharged home after treatment with vitamin C and digitalis.
Case VI.-Miss C. S., aged 64. Four years previously had had a gastrectomy for a duodenal ulcer after repeated bouts of melkna. She attended in March 1957: one month before she had bled severely for twenty-four hours after dental extraction. Investigation showed a slight hypochromic anamia, a leucocyte count of 12,000/c.mm. and platelet count between 930,000 and 1,130,000/c.mm. on three occasions. There was no enlargement of liver, spleen or lymph nodes in any of these secondary cases. INVESTIGATION OF HAEMOSTATIC FUNCTION Routine investigations of hemostatic function in both primary and secondary cases did not detect any abnormality, except for the bleeding time (Duke's method), in Cases I and 1II, where abnormal prolongation was found on one occasion only in Case I (eight minutes), and two occasions in Case III (thirty-eight minutes and twenty minutes). The Hess test, coagulation time (Lee and White), prothrombin time and clot retraction were all normal. Platelet aggregation appeared to be increased in stained films, but was not excessive in wet preparations; platelet morphology appeared normal.
In view of the paradoxical association, especially in the first 3 patients, between the marked -thrombocythmemia and the episodes of hemorrhage, it was considered of interest to investigate the behaviour of their platelets in other aspects of hemostatic function. Investigation of thromboplastin generation by the technique described by Biggs and Douglas (1953) was carried out: comparisons were made using three normal reagents (alumina plasma, for factor V and A.H.G., serum for factor VII and Christmas factor and platelet-poor plasma substrate), the variable factor being the platelet suspensions prepared from our patients and 3 normal controls. Platelet suspensions were prepared using the technique of Macfarlarin and Biggs (1955), being first standardized at 100,000/c.mm. by direct counting under phase con--trast with suitable saline dilution; the tests were repeated using platelet suspensions approxi--mating to the number in the blood (the controls were standardized at approximately 250,000 -platelets/c.mm.). The 3 cases designated as secondary thrombocythxemia were similarly investigated but only at platelet concentrations of 100,000/c.mm.
Proceedings of the Royal Socity of Medictne 44 Thomboplastin generation was followed for six minutes. From a thromboplastin dilution curve (Fig. 1 ) the percentages of thromboplastin were derived.
RESULTS
From Fig. 2 , where comparable numbers of platelets were used in patients and controls, it can be seen that thromboplastin generation was impaired for the first two minutes in all 3 cases of primary thrombocythemia. Complete generation was only found in 1 patient, and here it was delayed, rising to normal at the fifth minute.
When the platelet concentrations of the patients investigated were used at the abnormally high levels found in their blood, a delay in thromboplastin formation was again seen as shown in Fig. 3 . In only 1 patient was a normal level of thromboplastin obtained within the test period. In Case III the thromboplastin generation at the higher concentration of platelets was verv poor and markedly less than at 100,000/c.mm. (a possible reason for this discrepancy will be discussed later).
In Cases IV, V and VI, which were considered as secondary thrombocythaemia, thromboplastin generation was normal as seen in Fig. 4 , a 100% level being reached by the third minute in 2 cases and by the fourth minute in 1. 
DIscussIoN
While some authors (Jasinki, 1949) have doubted that primary thrombocythemia is an entity, in our 3 patients there was no evidence to suggest that the thrombocythemia was secondary to any other condition such as leuktmia or other myeloproliferative disorder. The clinical and pathological features of primary thrombocythmmia have been recently reviewed by Hardisty and Wolff (1955) . They describe the clinical course as being associated with repeated hemorrhages from various sites with, in some cases, an additional tendency towards spontaneous venous thrombosis. In our 3 patients there were abnormal hwmorrhages; Case I suffered repeated epistaxes, in Case II there was hematuria and unaccountable haemorrhage occurred into the tissues and in Case III there was severe hmmorrhage following dental extraction.
Hardisty and Wolff described arterial thrombosis in 1 patient of their series. In our Case II l the sudden onset of right hemiplegia and also cardiographic evidence of coronary infarction in a young man is strongly suggestive of arterial thrombosis; in addition this patient had required bilateral sympathectomy to relieve ischoemia of the feet. This is not an isolated association in thrombocytheemia; in a search through the literature we have found no less than 7 further cases with an associated ischemia of the feet. The case of Epstein and Kretz (1930) showed gangrene of the toes. A case described by Rowlands and Vaizey (1938) showed superficial gangrene of two toes with separation of small sloughs. Fanger et al. (1954) described a man with absent peripheral pulses in the lower limbs and incipient gangrene of the right great toe. Pridlah et al. (1955) described 4 cases of primary thrombocythaemia and in 3 of these there were circulatory insufficiencies demonstrable in the legs. Hardisty and Wolff (1955) noted 1 patient in their series who showed ischamic ulceration of the right fifth toe.
The association was so strong that we feel that there is sufficient evidence to describe this as a definite syndrome. The mechanism of the ischiemia of the lower limbs is obscure but is presumably associated with dependency, stagnation and an increased liability to thrombosis associated with the high platelet count.
The occurrence of heemorrhage in primary thrombocythaemia would appear to be paradoxical as platelets are enormously increased. However, by the thromboplastin-generation test we have shown that the platelet factor for thromboplastin formation was impaired in all 3 cases; this impairment was still present when the tests were repeated, using platelets in numbers comparable to the abnormally high levels in these patients.
All other tests of heemostatic function, apart from the bleeding time, are normal in these cases, and it seems reasonable to assume that an abnormality in the platelets is responsible for the hemorrhagic tendency.
These findings in primary thrombocythiemia agree with those of Hardisty and Wolff, who also demonstrated that in 12 cases of non-hiemorrhagic thrombocytheemia secondary to other causes such as myeloid leukxemia, polycytheemia vera, and myelofibrosis, there was no impairment of thromboplastin generation. Our Cases IV, V and VI were all considered as secondary thrombocytheemia and all were found to have abnormally high platelet counts soon after hlemorrhage; their bleeding times were all normal.
Clinical distinction between primary and secondary types may be very difficult. Case III, for example, was noted to have thrombocytheemia soon after a severe hiemorrhage following dental extraction. The bleeding time was, however, abnormally prolonged (thirty-eight minutes) and the thromboplastic function of the platelets was poor. It may often be difficult to decide whether the heemorrhage results from thrombocythaemia or is the cause.
The association between high platelet counts and poor platelet function could be explained in a number of ways. Are these platelets being formed so rapidly that they are deficient in some essential haemostatic factor? It has been shown that these platelets are deficient in another factor, 5-hydroxytryptamine (serotonin), although the whole blood serotonin is not reduced owing to the thrombocythemia. Alternatively is there some impairment in the mechanism for removing platelets so that there is an undue proportion of ageing platelets which are probably inefficient? Stefanini and Dameshek (1953) established that transfused platelets only survive for a maximum period of four to five days. This is true even after splenectomy as has been shown by our department (Bell et al., 1956) . We have also demonstrated that platelets stored in siliconed containers for more than four to five days are ineffectual in arresting hamorrhage in thrombocytopenia.
In our third case the thromboplastin-generation at the higher concentration of platelets was very poor and markedly less than at the 100,000/c.mm. level. It is interesting that Spaet, Bauer and Melamed (1956) have recorded an anticoagulant activity of platelets at high concentrations in a patient with haemorrhagic thrombocytheemia by the thromboplastin-generation test. They also found anticoagulant activity of normal platelets when concentrated to thrombocythimic levels.
The question of anticoagulant action of normal platelets at high concentrations should be pursued further as a possible cause of himorrhage.
The majority of authors who have described this condition consider that it is a form of myeloproliferation. Most cases have shown an increase in megakaryocytes in the bonemarrow with marked platelet budding. We found a moderate increase of megakaryocytes in Case III but have only studied the marrow ourselves in one other case (Case II) where the films unfortunately showed diminished cellularity, probably due to hemodilution.
Abnormality of the spleen has been commented on by others; Epstein and Kretz (1930) and Fanger et al. (1954) have noted atrophy of the spleen associated with thrombocythimia, whereas Rowlands and Vaizey (1938) and Owren (1943) noted splenomegaly.
In our cases, only 1 showed slight clinical enlargement of the spleen.
While the etiology of the condition remains obscure, we consider that there is now sufficient evidence to recognize primary hemorrhagic thrombocythemia as an entity. SPAET, T. M., BAUER, S., and MELAMED, S. (1956) Arch. intern. Med., 98, 377. STEFANINI, M., and DAMESHEK, W. (1953) New Engl. J. Med., 248, 797 . DISCUSSION Dr. R. M. Hardisty said that Dr, Chanarin had shown that the rate of plasma clearance of folic acid was increased in cases of pernicious anwmia, but within normal limits in the anemia associated with anticonvulsant drugs. He asked Dr. Chanarin to explain why he classed both these conditions as instances of the failure of utilization of folic acid and how these findings threw light on the interrelationship of folic acid and vitamin B12.
He asked Dr. Shaw whether he regarded the results of his thromboplastin-generation tests on the platelets of the haemorrhagic group as significantly different from the controls.
Dr. G. I. C. Ingram, on Dr. Shaw's paper, suggested that all the cases might have been examples of primary thrombocythmmia, with the possible exception of Case IV, in which the platelet count returned spontaneously to normal. From the clinical point of view, bleeding might have been associated with a pre-existing thrombocythtmia, rather than having caused a "secondary" rise in platelet count. In the thromboplastin generation test he had found that thrombocythmmia platelets could usually be shown to be more inhibitory than normal platelets when both were tested at concentrations over about 106 per c.mm. The platelets from the 3 cases included in Fig. 4 might have been found to be more inhibitory than normal had they been tested at a concentration ten times higher.
Dr. H. E. M. Kay questioned Dr. Chanarin's interpretation of the folic acid absorption curves in the cases of megaloblastic anmmia of pregnancy and suggested that the low plasma levels were due to rapid clearance rather than defective absorption.
Dr. D. D. Mollin, in reply to a question, agreed that it was true that patients with megaloblastic anatmia due to anticonvulsants might respond to treatment with vitamin B12, particularly if relatively large doses were given. In this they resembled some patients with megaloblastic anemia of the puerperium. It was difficult to imagine why they did this. Occasionally, these patients might be vitamin-BI2-deficient (Kidd and Mollin, 1957) . However, only 2 out of 20 patients, whose sera had been assayed, had subnormal serum vitamin B12 levels, and htmatological responses had been seen in patients whose serum B12 levels, although low, were within the normal range (Badenoch, 1954) .
Even when treatment with vitamin B12 induced a remission in these patients, this was incomplete unless the anticonvulsant drug was also stopped. The htmoglobin concentration might rise to within the normal range but there was residual macrocytosis and the marrow would still (1957) Brit. med. J., ii, 974.
Dr. S. Shaw, in reply to Dr. Ingram, pointed out that at the time when this work was being carried out the authors had not any information concerning the possible anticoagulant effect of platelets at high concentrations and that further tests using normal platelets and platelets from patients with primary and secondary thrombocythtmia would elucidate this point.
In reply to Dr. Hardisty, Dr. Shaw said that while the results Qf thromboplastin-generation tests in the secondary thrombocythvmic group were similar to those of the controls, he considered that thromboplastin-generation in the three cases of primary hemorrhagic thrombocythmmia was significantly slower. It was interesting that the difference was greatest at the platelet concentration found in the blood, and in Case 3 which showed the most prolonged bleeding time.
Dr. Chanarin, in reply to Dr. Hardisty, said that although folic acid deficiency appeared to determine the development of anemia in Addisonian pernicious antmia, these patients did not respond well, if at all, to small doses of folic acid, and only responded to large doses. If, as seems likely, a folicacid-like compound is the final "antimegaloblastic" substance, then in B12 deficiency there must be some difficulty in either converting pteroylglutamic acid into this active form, or in maintaining it in that form. In this sense B12 deficiency appeared to interfere with the utilization of folic acid.
The mode of action of the anticonvulsant drugs appeared more analogous to the action of the folicacid antagonists.
In reply to Dr. Kay, Dr. Chanarin said that the low serum folic acid levels found in the absorption tests in pregnancy were unlikely to be due to more rapid clearance of the absorbed folic acid from the plasma since all the patients were "saturated" with folic acid by giving them large doses of folicacid for four days before the test. A 24-hour gap was then allowed for the clearance of all folic acid from the plasma before an absorption test was performed. An increase in plasma volume in preg-nancy, however, could contribute-to some lowering of the serum levels when a standard dose of folic acid was used. The observations were therefore repeated in both pregnancy and control subjects using an oral dose of folic acid adjusted to body weight, and the original observations were confirmed-
